These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22098276)

  • 21. Editorial comment on: HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
    Colombo R
    Eur Urol; 2010 Jan; 57(1):93-4. PubMed ID: 19345471
    [No Abstract]   [Full Text] [Related]  

  • 22. Get with the guidelines to improve heart care.
    LaBresh KA
    Ital Heart J; 2004 Jul; 5(7):489-93. PubMed ID: 15487264
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic options and treatment of muscle invasive bladder cancer.
    O'Connor RC; Alsikafi NF; Steinberg GD
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):511-22. PubMed ID: 12113083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 AND TIS).
    Lamm DL
    J Urol; 2000 Jun; 163(6):1890-1. PubMed ID: 10799217
    [No Abstract]   [Full Text] [Related]  

  • 25. Understanding the variation in treatment intensity among patients with early stage bladder cancer.
    Hollingsworth JM; Zhang Y; Krein SL; Ye Z; Hollenbeck BK
    Cancer; 2010 Aug; 116(15):3587-94. PubMed ID: 20564128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction.
    Glickman SW; Boulding W; Manary M; Staelin R; Roe MT; Wolosin RJ; Ohman EM; Peterson ED; Schulman KA
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):188-95. PubMed ID: 20179265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Predictive factors and long term carcinogenic results of patients who no longer have residual tumors (stage pT0) on specimens of total cystectomy carried out for cancer of the bladder].
    Hitier M; Marconnet L; Luyckx F; Branchereau J; Braud G; Karam G; Bouchot O; Rigaud J
    Prog Urol; 2010 Feb; 20(2):130-7. PubMed ID: 20142054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guideline-adherent care vs quality care in cancer patients: twins or distant cousins?
    Chen RC
    JAMA Intern Med; 2013 Apr; 173(7):569-70. PubMed ID: 23460294
    [No Abstract]   [Full Text] [Related]  

  • 29. Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?
    Soloway MS; Arianayagam M
    Urology; 2010 Oct; 76(4):794-6. PubMed ID: 20932403
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
    Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
    Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality control in urodynamics: Analysis of an international multi-center study.
    Renganathan A; Cartwright R; Cardozo L; Robinson D; Srikrishna S
    Neurourol Urodyn; 2009; 28(5):380-4. PubMed ID: 19090592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 33. Adherence to professional guidelines for patients with urinary incontinence by general practitioners: a cross-sectional study.
    Albers-Heitner P; Berghmans B; Nieman F; Lagro-Janssen T; Winkens R
    J Eval Clin Pract; 2008 Oct; 14(5):807-11. PubMed ID: 18462277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a strategy for a longitudinal study of patients with bladder cancer. National Bladder Cancer Collaborative Group A (NBCCGA).
    Cancer Res; 1977 Aug; 37(8 Pt 2):2898-906. PubMed ID: 326396
    [No Abstract]   [Full Text] [Related]  

  • 35. Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?
    Smolders M; Laurant M; Verhaak P; Prins M; van Marwijk H; Penninx B; Wensing M; Grol R
    Med Care; 2010 Mar; 48(3):240-8. PubMed ID: 20125045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How updating textual clinical practice guidelines impacts clinical decision support systems: a case study with bladder cancer management.
    Bouaud J; Séroussi B; Brizon A; Culty T; Mentré F; Ravery V
    Stud Health Technol Inform; 2007; 129(Pt 2):829-33. PubMed ID: 17911832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In search of the perfect crystal ball for Ta urothelial cancer.
    Chin JL
    Eur Urol; 2010 Jan; 57(1):21-2; discussion 23-4. PubMed ID: 19748172
    [No Abstract]   [Full Text] [Related]  

  • 39. Organ conservation and reconstruction in advanced bladder cancer.
    Sternberg CN
    Prog Clin Biol Res; 1991; 370():131-42. PubMed ID: 1924442
    [No Abstract]   [Full Text] [Related]  

  • 40. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control.
    Luke C; Tracey E; Stapleton A; Roder D
    Intern Med J; 2010 May; 40(5):357-62. PubMed ID: 19460053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.